Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence

Annals of Surgical Oncology

Volumn 18, Issue 6, 2011, Pages 1590-1598

  De Campos Lobato, Luiz Felipe ^a   Stocchi, Luca ^a   Da Luz Moreira, Andre ^a,b   Geisler, Daniel ^a   Dietz, David W ^a   Lavery, Ian C ^a   Fazio, Victor W ^a   Kalady, Matthew F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROSPECTIVE STUDY; RECTUM CANCER; RECTUM RESECTION; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79956219437     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1506-1     Document Type: Article

References (71)

1. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin. 59 225 249 19474385 10.3322/caac.20006
2. R Sauer H Becker W Hohenberger C Rodel C Wittekind R Fietkau, et al. 2004 Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med. 351 1731 1740 15496622 10.1056/NEJMoa040694 1:CAS:528:DC%2BD2cXovFSksbo%3D (Pubitemid 39383208)
3. Bujko K, Michalski W, Kepka L, Nowacki MP, Nasierowska-Guttmejer A, Tokar P, et al. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: an analysis of outcomes in a randomized trial. Int J Radiat Oncol Biol Phys. 20071;67:369-77. (Pubitemid 46127610)
4. AK Chan A Wong D Jenken J Heine D Buie D Johnson 2005 Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy Int J Radiat Oncol Biol Phys. 61 665 677 15708244 10.1016/j.ijrobp.2004.06.206 (Pubitemid 40247960)
5. BD Minsky AM Cohen WE Enker L Saltz JG Guillem PB Paty, et al. 1997 Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer Int J Radiat Oncol Biol Phys. 37 289 295 9069299 10.1016/S0360-3016(96)00487-7 1:CAS:528:DyaK2sXisVeitLY%3D (Pubitemid 27138711)
6. P Rouanet JM Fabre JB Dubois F Dravet B Saint Aubert J Pradel, et al. 1995 Conservative surgery for low rectal carcinoma after high-dose radiation. functional and oncologic results Ann Surg. 221 67 73 7826163 10.1097/00000658-199501000-00008 1:STN:280:DyaK2M7is1Ohug%3D%3D
7. F Stipa DB Chessin J Shia PB Paty M Weiser LK Temple, et al. 2006 A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography Ann Surg Oncol. 13 1047 1053 16865595 10.1245/ASO.2006.03.053 (Pubitemid 44337963)
8. VK Mehta J Poen J Ford PS Edelstein M Vierra AJ Bastidas, et al. 2001 Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer Dis Colon Rectum. 44 52 58 11805563 10.1007/BF02234821 1:STN:280:DC%2BD38%2FnvVGitg%3D%3D (Pubitemid 32105874)
9. JS Kim JS Kim MJ Cho KS Song WH Yoon 2002 Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer Int J Radiat Oncol Biol Phys. 54 403 408 12243814 10.1016/S0360-3016(02)02856-0 1:CAS:528:DC%2BD38XntVWqtL4%3D (Pubitemid 35286804)
10. JG Guillem DB Chessin AM Cohen J Shia M Mazumdar W Enker, et al. 2005 Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer Ann Surg. 241 829 836 15849519 10.1097/01.sla.0000161980.46459.96 discussion 836-8. (Pubitemid 40604929)
11. JF Bosset V Magnin P Maingon G Mantion EP Pelissier M Mercier, et al. 2000 Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial Int J Radiat Oncol Biol Phys. 46 323 327 10661338 10.1016/S0360-3016(99)00411-3 1:STN:280:DC%2BD3c7isV2mtg%3D%3D (Pubitemid 30067781)
12. LF de Campos-Lobato L Stocchi A da Luz Moreira MF Kalady D Geisler D Dietz, et al. 2010 Downstaging without complete pathologic response after neoadjuvant treatment improves cancer outcomes for cIII but not cII rectal cancers Ann Surg Oncol. 17 1758 1766 20131015 10.1245/s10434-010-0924-4
13. IC Lavery F Lopez-Kostner RJ Pelley RM Fine 2000 Treatment of colon and rectal cancer Surg Clin North Am. 80 535 569 10836006 10.1016/S0039-6109(05) 70200-0 1:STN:280:DC%2BD3c3psFOisQ%3D%3D ix. (Pubitemid 30227069)
14. F Lopez-Kostner IC Lavery GR Hool LA Rybicki VW Fazio 1998 Total mesorectal excision is not necessary for cancers of the upper rectum Surgery. 124 612 617 9780979 10.1067/msy.1998.91361 1:STN:280:DyaK1cvlsValtg%3D%3D discussion 617-8 (Pubitemid 28463255)
15. RJ Heald RD Ryall 1986 Recurrence and survival after total mesorectal excision for rectal cancer Lancet. 1 1479 1482 2425199 10.1016/S0140-6736(86) 91510-2 1:STN:280:DyaL283lsFylug%3D%3D (Pubitemid 16095660)
16. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti III A. AJCC-Cancer Staging Manual. 7th ed., New York: Springer; 2010.
17. Greene FL, Page DL, Fleming ID, Fritz AG, Balch MC, Haller DG, et al. AJCC Cancer Staging Manual. New York: Springer; 2002.
18. SJ Pocock TC Clayton DG Altman 2002 Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls Lancet. 359 1686 1689 12020548 10.1016/S0140-6736(02)08594-X (Pubitemid 34518535)
19. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons, Inc.; 2000.
20. SEER cancer statistics review [homepage on the Internet]. Bethesda, MD: National Cancer Institute. 2009 May 29, 2009 [cited 1975-2006]. Available at: http://seer.cancer.gov/csr/1975-2006/.
21. A Wibe B Moller J Norstein E Carlsen JN Wiig RJ Heald, et al. 2002 A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit Dis Colon Rectum. 45 857 866 12130870 10.1007/s10350-004-6317-7 (Pubitemid 34761463)
22. E Carlsen E Schlichting I Guldvog E Johnson RJ Heald 1998 Effect of the introduction of total mesorectal excision for the treatment of rectal cancer Br J Surg. 85 526 529 9607540 10.1046/j.1365-2168.1998.00601.x 1:STN:280: DyaK1c3mvVGmtA%3D%3D (Pubitemid 28175451)
23. E Schlichting E Carlsen 1998 Introduction of a new surgical technique in rectal cancer Tidsskr Nor Laegeforen. 118 1846 1849 9638050 1:STN:280: DyaK1czgtFyqtQ%3D%3D (Pubitemid 128687037)
24. JN Wiig E Carlsen O Soreide 1998 Mesorectal excision for rectal cancer: a view from Europe Semin Surg Oncol. 15 78 86 9730413 10.1002/(SICI)1098- 2388(199809)15:2<78::AID-SSU4>3.0.CO;2-2 1:STN:280:DyaK1czpvVWrsw%3D%3D (Pubitemid 28387984)
25. L Collette JF Bosset M den Dulk F Nguyen L Mineur P Maingon, et al. 2007 Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European organisation for research and treatment of cancer radiation oncology group J Clin Oncol. 25 4379 4386 17906203 10.1200/JCO.2007.11.9685 1:CAS:528:DC%2BD2sXht1ertrjO (Pubitemid 350013843)
26. JE Krook CG Moertel LL Gunderson HS Wieand RT Collins RW Beart, et al. 1991 Effective surgical adjuvant therapy for high-risk rectal carcinoma N Engl J Med. 324 709 715 1997835 10.1056/NEJM199103143241101 1:STN:280: DyaK3M7kvVKmsw%3D%3D
27. PA Hurst WG Prout JM Kelly JJ Bannister RT Walker 1982 Local recurrence after low anterior resection using the staple gun Br J Surg. 69 275 276 7074339 10.1002/bjs.1800690515 1:STN:280:DyaL387otlCgtw%3D%3D (Pubitemid 12101601)
28. JC Goligher CE Dukes HJ Bussey 1951 Local recurrences after sphincter saving excisions for carcinoma of the rectum and rectosigmoid Br J Surg. 39 199 211 14895939 10.1002/bjs.18003915504 1:STN:280:DyaG38%2Fis1Snuw%3D%3D
29. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444-50.
30. C Capirci V Valentini L Cionini A De Paoli C Rodel R Glynne-Jones, et al. 2008 Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients Int J Radiat Oncol Biol Phys. 72 99 107 18407433 10.1016/j.ijrobp.2007.12.019
31. D Hahnloser H Nelson LL Gunderson I Hassan MG Haddock MJ O'Connell, et al. 2003 Curative potential of multimodality therapy for locally recurrent rectal cancer Ann Surg. 237 502 508 12677146 (Pubitemid 38176430)
32. F Pacelli AP Tortorelli F Rosa M Bossola AM Sanchez V Papa, et al. 2010 Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy Ann Surg Oncol. 17 152 162 19834766 10.1245/s10434-009-0737-5
33. KC Peeters CA Marijnen ID Nagtegaal EK Kranenbarg H Putter T Wiggers, et al. 2007 The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma Ann Surg. 246 693 701 17968156 10.1097/01.sla.0000257358.56863.ce (Pubitemid 350035641)
34. NR Ahmad D Nagle 1997 Long-term results of preoperative radiation therapy alone for stage T3 and T4 rectal cancer Br J Surg. 84 1445 1448 9361610 10.1002/bjs.1800841029 1:STN:280:DyaK1c%2FislKrsw%3D%3D (Pubitemid 27443455)
35. J Garcia-Aguilar E Hernandez de Anda P Sirivongs SH Lee RD Madoff DA Rothenberger 2003 A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum. 46 298 304 12626903 10.1007/s10350-004-6545-x (Pubitemid 36331646)
36. MW Onaitis RB Noone R Fields H Hurwitz M Morse P Jowell, et al. 2001 Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival Ann Surg Oncol. 8 801 806 11776494 10.1007/s10434-001-0801-2 1:STN:280:DC%2BD38%2FkvVyntg%3D%3D (Pubitemid 34003329)
37. S Pucciarelli P Toppan ML Friso V Russo L Pasetto E Urso, et al. 2004 Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome Dis Colon Rectum. 47 1798 1807 15622571 10.1007/s10350-004-0681-1 (Pubitemid 40064422)
38. K Bujko MP Nowacki A Nasierowska-Guttmejer W Michalski M Bebenek M Pudelko, et al. 2004 Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy Radiother Oncol. 72 15 24 15236870 10.1016/j.radonc.2003.12.006 1:STN:280:DC%2BD2czpsVSmsQ%3D%3D (Pubitemid 38952855)
39. CA Messick J Sanchez KL Dejulius JM Church MF Kalady 2009 Genetic and molecular diversity of colon cancer hepatic metastases Surgery. 146 227 231 19628078 10.1016/j.surg.2009.06.003
40. MF Kalady LF de Campos-Lobato L Stocchi D Geisler D Dietz IC Lavery, et al. 2009 Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer Ann Surg. 250 582 589 19710605
41. H Tulchinsky E Shmueli A Figer JM Klausner M Rabau 2008 An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer Ann Surg Oncol. 15 2261 2267 10.1245/s10434-008-9892-3
42. de Campos-Lobato LF, Geisler D, da Luz Moreira A, Stocchi L, Dietz D, Kalady MF. Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery. J Gastrointest Surg. 2010 [Epub ahead of print].
43. Timing of rectal cancer response to chemoradiation [homepage on the Internet]. Bethesda, MD, USA: National Institutes of Health. 2010 01/29/2010 [cited 01/29/2010]. Available at: http://projectreporter.nih.gov/project-info- description.cfm?aid=7928480.
44. JF Bosset L Collette G Calais L Mineur P Maingon L Radosevic-Jelic, et al. 2006 Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med. 355 1114 1123 16971718 10.1056/NEJMoa060829 1:CAS:528:DC%2BD28XpsFKkur8%3D (Pubitemid 44394918)
45. JP Gerard T Conroy F Bonnetain O Bouche O Chapet MT Closon-Dejardin, et al. 2006 Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 J Clin Oncol. 24 4620 4625 17008704 10.1200/JCO.2006.06.7629 (Pubitemid 46630960)
46. T Borschitz D Wachtlin M Mohler H Schmidberger T Junginger 2008 Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer Ann Surg Oncol. 15 712 720 18163173 10.1245/s10434-007-9732-x
47. MD Bonnen MT Ballo JN Myers AS Garden EM Diaz Jr JE Gershenwald, et al. 2004 Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck Cancer. 100 383 389 14716775 10.1002/cncr.11921 (Pubitemid 38063649)
48. T Borschitz 2008 In reply: local excision as an optional tool to individualize treatment of rectal cancer Ann Surg Oncol. 15 2630 2631 10.1245/s10434-008-9979-x
49. MJ Hershman AS Myint CA Makin 2003 Multi-modality approach in curative local treatment of early rectal carcinomas Colorectal Dis. 5 445 450 12925078 10.1046/j.1463-1318.2003.00502.x 1:STN:280:DC%2BD3szovVeguw%3D%3D (Pubitemid 37080652)
50. CJ Kim TJ Yeatman D Coppola A Trotti B Williams JS Barthel, et al. 2001 Local excision of T2 and T3 rectal cancers after downstaging chemoradiation Ann Surg. 234 352 358 11524588 10.1097/00000658-200109000-00009 1:STN:280: DC%2BD3MvotVylsA%3D%3D discussion 358-9. (Pubitemid 32847072)
51. E Lezoche M Guerrieri AM Paganini M Baldarelli A De Sanctis G Lezoche 2005 Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery Br J Surg. 92 1546 1552 16252312 10.1002/bjs.5178 1:STN:280:DC%2BD2Mnot1Wkuw%3D%3D (Pubitemid 41785295)
52. T Tjandra 2006 Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery Tech Coloproctol. 10 158 16826339 10.1007/s10151-006-0273-2 1:STN:280: DC%2BD28vgsFOrsQ%3D%3D discussion 158-9.
53. L Ruo JG Guillem BD Minsky SH Quan PB Paty AM Cohen 2002 Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers Int J Colorectal Dis. 17 54 58 12018456 10.1007/s003840100327 1:STN:280:DC%2BD383nslGltg%3D%3D (Pubitemid 41398993)
54. SR Schell RA Zlotecki WM Mendenhall RW Marsh JN Vauthey EM Copeland 3rd 2002 Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy J Am Coll Surg. 194 584 590 12025835 10.1016/S1072-7515(02)01128-6 discussion 590-1. (Pubitemid 34496653)
55. A Habr-Gama RO Perez W Nadalin J Sabbaga U Ribeiro Jr AH Silva e Sousa Jr, et al. 2004 Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results Ann Surg. 240 711 717 15383798 discussion 717-8.
56. E Mignanelli L de Campos-Lobato L Stocchi I Lavery D Dietz 2010 Downstaging following CRT for locally advanced rectal cancer: is there more (tumor) than meets the eye? Dis Colon Rectum. 53 251 256 20173469 10.1007/DCR.0b013e3181bcd3cc
57. C Ratto V Valentini AG Morganti B Barbaro C Coco L Sofo, et al. 2003 Combined-modality therapy in locally advanced primary rectal cancer Dis Colon Rectum. 46 59 67 12544523 10.1007/s10350-004-6497-1 (Pubitemid 36105832)
58. O Zmora GM Dasilva B Gurland R Pfeffer M Koller JJ Nogueras, et al. 2004 Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy? Dis Colon Rectum. 47 1607 1612 15540288 10.1007/s10350-004-0673-1 (Pubitemid 39331970)
59. A Grann BD Minsky AM Cohen L Saltz JG Guillem PB Paty, et al. 1997 Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer Dis Colon Rectum. 40 515 522 9152176 10.1007/BF02055370 1:STN:280: DyaK2s3ps1OjtQ%3D%3D (Pubitemid 27200688)
60. A de la Torre S Ramos FJ Valcarcel A Candal CA Regueiro J Romero, et al. 1999 Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer Int J Radiat Oncol Biol Phys. 45 629 634 10.1016/S0360-3016(99)00225-4 (Pubitemid 29462642)
61. J Seong JH Cho NK Kim JS Min CO Suh 2001 Preoperative chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancer Int J Radiat Oncol Biol Phys. 50 435 439 11380231 10.1016/S0360-3016(00)01585-6 1:CAS:528:DC%2BD3MXjsFensrc%3D (Pubitemid 32472271)
62. SP Hiotis SM Weber AM Cohen BD Minsky PB Paty JG Guillem, et al. 2002 Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients J Am Coll Surg. 194 131 135 11848629 10.1016/S1072-7515(01)01159-0 discussion 135-6. (Pubitemid 34118868)
63. BD O'Neill G Brown RJ Heald D Cunningham DM Tait 2007 Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer Lancet Oncol. 8 625 633 17613424 10.1016/S1470-2045(07)70202-4 (Pubitemid 47008889)
64. T Watanabe 2008 Chemoradiotherapy and adjuvant chemotherapy for rectal cancer Int J Clin Oncol. 13 488 497 19093175 10.1007/s10147-008-0849-0 1:CAS:528:DC%2BD1cXhsFSrurnM
65. N Wolmark H Rockette B Fisher DL Wickerham C Redmond ER Fisher, et al. 1993 The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from national surgical adjuvant breast and bowel project protocol C-03 J Clin Oncol. 11 1879 1887 8410113 1:STN:280:DyaK2c%2FhsFajtw%3D%3D (Pubitemid 23304611)
66. LL Gunderson JM Jessup DJ Sargent FL Greene AK Stewart 2010 Revised TN categorization for colon cancer based on national survival outcomes data J Clin Oncol. 28 264 271 19949014 10.1200/JCO.2009.24.0952
67. JJ Tjandra JW Kilkenny WD Buie N Hyman C Simmang T Anthony, et al. 2005 Practice parameters for the management of rectal cancer (revised) Dis Colon Rectum. 48 411 423 15875292 10.1007/s10350-004-0937-9 (Pubitemid 40767859)
68. NN Baxter DJ Virnig DA Rothenberger AM Morris J Jessurun BA Virnig 2005 Lymph node evaluation in colorectal cancer patients: a population-based study J Natl Cancer Inst. 97 219 225 15687365 10.1093/jnci/dji020 (Pubitemid 40277372)
69. National quality forum endorsed commission on cancer measures for quality of cancer care for breast and colorectal cancers [homepage on the Internet]. Chicago, IL: The American College of Surgeons. 2007 May 14, 2007 [cited 02/12/2010]. Available at: http://www.facs.org/cancer/qualitymeasures.html.
70. SG de la Fuente RJ Manson KA Ludwig CR Mantyh 2009 Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens J Gastrointest Surg. 13 269 274 10.1007/s11605-008-0717-2
71. A Habr-Gama RO Perez I Proscurshim V Rawet DD Pereira AH Sousa, et al. 2008 Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon Rectum. 51 277 283 18183463 10.1007/s10350-007-9148-5